| Literature DB >> 33238924 |
Danilo Cereda1, Antonio Federici2, Angela Guarino3, Grazia Serantoni4, Liliana Coppola5, Patrizia Lemma6, Paolo Giorgi Rossi7.
Abstract
BACKGROUND: High participation and performance are necessary conditions for the effectiveness of breast cancer screening programs. Here we describe the process to define and test a planning software application and an audit cycle based on the PRECEDE-PROCEED model applied to improving breast cancer screening. We developed a planning software application following the phases of the PRECEDE-PROCEED model. The application was co-designed by local cancer screening program coordinators. An audit model was also developed. The revised application and the audit model were tested by all the coordinators of 15 breast cancer screening programs in the region of Lombardy in a 3-day workshop. The project plans produced using the application were compared with those produced in the previous year for clarity and completeness.Entities:
Keywords: Breast cancer; Health intervention planning; Mass screening; PRECEDE-PROCEED model, audit
Mesh:
Year: 2020 PMID: 33238924 PMCID: PMC7687705 DOI: 10.1186/s12889-020-09842-8
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
The public health and screening organization in Region of Lombardy
| Functions | ||
|---|---|---|
| National Healthcare System | Italian Minister of Health (IMH) | The parliament sets the Essential Levels of Care (LEA) and the National Health Fund. The IMH, with the support of the National Screening Monitoring Centre, agrees with regional governments the operational definition of the screening LEA, the monitoring of LEA-related indicators, objectives for implementation and quality assurance, and budget criteria for fund allocation (linked to objectives). The National Plan of Prevention, the national guidelines for screening and the screening reporting system are the main tools for this task. |
| Healthcare System of the Region of Lombardy | General directorate of Welfare of Region of Lombardy (DGW-LR) Prevention Unit | -defines budgets, rules, objectives for Local Health Authorities, which are the payers, and for hospital and clinic trusts (called Territorial Health Social Trusts), which are the providers; - coordinates and supports Local Health Authorities; - manages regional “monitoring system” (database) to guarantee oncologic screening to all citizens of the Region of Lombardy evaluating data reported by the LHAs; -reports performance indicators to IMH. |
8 Local Health Authorities (LHA) – including 15screening centers | - make agreements with the Territorial Health Social Trusts and with the hospitals with regard to the number of medical exams of screenings (mammograms, fecal immunologic tests, colonoscopies, pap tests, etc) - control the quality of medical exams -report data to DGW-LR - manage the “call-recall system” (send letters, recall, manage website, etc.) -manage communications with patients (by e-mails, call center) -elaborate performance and early outcome population-based indicators - evaluate the performance of each hospital and refer the data of activities to DGW-LR. | |
| public accredited hospitals (27) and private accredited hospitals | - do medical exams of screening, assessment and treatment - report data to LHAs |
Description of the PRECEDE-PROCEED model according to Green and Kreuter [17] and its tailoring for screening program setting as developed in the region of Lombardy audit model
| original Green & Kreuter | tailored for screening setting | |
|---|---|---|
| Phase 1 - Social Diagnosis | Identifies and evaluates the social problems which impact the quality of life of a specific population | The General directorate of Welfare of Region of Lombardy identifies outcomes and negotiates targets with Local Health authority (LHA) according to regional targets and local setting |
| Phase 2 - Epidemiological Diagnosis | Establishes program objective considering the target population | Screening program is described by indicators and epidemiological critical issues are identified |
| Phase 3 - Behavioral & Environmental Diagnosis | Establishes which factors are linked to health problems and, if modified, can sustain the change process (predisposing, enabling and reinforcing factors). | The LHA can read evidenced-based reviews on which factors are linked to health problems in screening setting and, if modifiable, can sustain the change process |
| Phase 4 - Education & Organizational Diagnosis | Identifies the presence of the factors categorized in Phase 3 | The LHA identifies the presence of evidence-based actions or best practices; analyzes the relationships with key partners; identifies other critical conditions. In this phase organizational critical issues are identified |
| Phase 5 - Administrative & Policy Diagnosis | Focuses on the administrative and organizational concerns, which must be considered prior to program implementation. Program objective has to be assessed as compatible with the administration and policy | LHA is asked to define priorities (high, medium, low, and very low) and possible solutions for every critical issue. If no solution is feasible, the resources needed must be quantified and sustainability must be verified. |
| Phase 6 – Implementation | Converts program objectives into actions through policy changes, regulation and organization | Converts program objectives into actions: output and outcome indicators are requested |
| Phase 7 - Process Evaluation | Evaluates the process of implementation | Evaluates the process of implementation at 3–6–9-12 months from the beginning of the intervention. |
| Phase 8 - Impact Evaluation | Measures the program effectiveness in terms of intermediate objectives and changes in predisposing, enabling, and reinforcing factors | Measures changes in the main indicators of screening uptake: participation and test coverage |
| Phase 9 - Outcome Evaluation | Measures change in terms of overall objectives and changes in health, social benefits or the quality of life. | Measures change in terms of efficacy of screening (sensitivity): interval cancer and advanced cancer incidence |
Indicators used for the social (A) and epidemiological diagnosis (B). In many cases there are international, national or locally defined standards. For the indicators included in the social diagnosis specific objectives should be agreed between the General directorate of Welfare of Region of Lombardy (DGW-LR) and the local health authorities (LHA)
| Indicators | Italian mandatory standards (LEA) | recommended standards a | standards set by the DGW-LR | Note |
|---|---|---|---|---|
| % coverage screening | > 55% | Ac | ||
| % advanced cancer screen detected (stage > = 2) at subsequent exams | < 25% | Ac | ||
| %screen detected cancers without staging | < 10% | Ac | ||
| % Participation rate | 75% | Ac | ||
| % letters not delivered | < 5% | A | ||
| % patients excluded post invitation | < 10% | A | ||
| % patients with “waiting for recall <=28 days” | > 90% | Ac | ||
| % people excluded before invitation on total population targetb | > 0% | Ac | ||
| % people invited on total population target | > 90% | Ac | ||
| % rate of interval cancers 0–11 months | < 10% | B | ||
| % rate of interval cancers 12–23 months | < 40% | B | ||
| % recall rate first exams | < 7% | A | ||
| % recall rate (subsequent examinations | < 5% | A | ||
| % screen-detected cancers compared to the total of cancers detected | > 30% | B | ||
| average call time (in months) | 24 | 24 | A | |
| rate of interval cancers × 1000 | < 3 | A | ||
| sensitivity (proportional incidence) | > 70% | A | ||
| sensitivity (screen detected / observed) | > 65% | A | ||
| % overall coverage (screening and extra screening) | > 80% | B | ||
| % PPV | > 7% | B | ||
| % prevalence | to define locally | B | ||
| Incidence | to define locally | B | ||
| rate of interval cancers ×1000 | < 1,5 | B | ||
| sensitivity (proportional incidence) | > 70% | B | ||
| sensitivity (screen detected / observed) | > 99% | B | ||
| % coverage 45–49 | > 50% | B |
A = indicators for social diagnosis; these indicators are mandatory and are defined by the regulatory system. Data for these indicators are collected centrally by the DGW-LR and standards are fixed
B = indicators only for epidemiological diagnosis, data are collected locally by the screening programs
aGISMA Italian scientific society of breast screening or European guidelines on Breast cancer
b the majority of screening centres don’t calculate this indicator
c mandatory
The outputs of the planning application. 7 reports
Local Health Authorities (LHA)
Results of the audits conducted in 2017 in four LHAs using the PRECEDE-PROCEED tool
| EPIDEMIOLOGICAL CRITICAL ISSUES | ORGANIZATIONAL CRITICAL ISSUES | LOW PRIORITY ISSUES | NOT SUSTAINABLE SOLUTIONS | CRITICAL ISSUES WITHOUT A SOLUTION | SOLUTIONS TO BE ACTIVATED | % SOLUTIONS TO BE ACTIVATED / ORGANIZATIONAL CRITICAL ISSUES | |
|---|---|---|---|---|---|---|---|
| LHA A | 25 | 90 | 14 | 21 | 1 | 54 | 60% |
| LHA B | 3 | 62 | 16 | 2 | 3 | 41 | 66% |
| LHA C | 4 | 22 | 7 | 2 | 5 | 8 | 36% |
| LHA D | 10 | 58 | 25 | 11 | 2 | 20 | 34% |
| TOT | 42 | 232 | 62 | 36 | 11 | 123 | 53% |